Crescent Biopharma, Inc. (CBIO) has a market capitalization of $537.91M and trades at $19.52. The 52-week range is 8.72-29.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 325.3, Earnings Per Share (EPS) of $0.06, annual revenue of $10.84M.
The stock has a beta of 1.30, operates in the Healthcare sector.
